Cochlear Limited (AU:COH)
ASX:COH
COH Stock Chart & Stats
AU$172.36
AU$1.87(0.62%)
At close: 4:00 PM EST
AU$172.36
AU$1.87(0.62%)
Day’s Range― - ―
52-Week RangeAU$160.00 - AU$319.56
Previous CloseN/A
Volume75.08K
Average Volume (3M)130.23K
Market Cap
AU$11.27B
Enterprise ValueAU$11.51B
Total Cash (Recent Filing)AU$187.10M
Total Debt (Recent Filing)AU$427.80M
Price to Earnings (P/E)26.4
Beta0.55
Next Earnings
Aug 13, 2026EPS Estimate
3.25Next Dividend Ex-DateN/A
Dividend Yield1.64%
Share Statistics
EPS (TTM)2.98
Shares Outstanding65,398,680
10 Day Avg. Volume116,122
30 Day Avg. Volume130,233
Financial Highlights & Ratios
PEG Ratio5.50
Price to Book (P/B)10.08
Price to Sales (P/S)8.39
P/FCF Ratio145.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$247.69Price Target Upside43.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)6.25
Revenue Forecast (FY)AU$2.44B
Bulls Say, Bears Say
Bulls Say
Financial GuidanceFY26 guidance implies 2H26 NPAT growth of +13-25%.
Market GrowthThe Nucleus Nexa is the first 'smart' implant to market, expected to attract both physicians and patients and see double-digit growth for implants.
Product LaunchWith the launch of a new implant – the Nucleus Nexa – offering an enhanced patient experience, there is optimism that the company can sustain its market-leading position.
Bears Say
Market SentimentUncertainty around near-term services growth has led to a downgrade of COH shares from Buy to Neutral.
Product VolumeProcessors experienced a decline in volumes due to a mix of cost of living and other factors, making the outlook for services sales less optimistic.
Sales EstimatesMid-term sales estimates fall 5-6% on lower services sales growth, which resulted in a decrease in the price target from AUD350 to AUD320.
Cochlear News
COH FAQ
What was Cochlear Limited’s price range in the past 12 months?
Cochlear Limited lowest share price was AU$160.00 and its highest was AU$319.56 in the past 12 months.
What is Cochlear Limited’s market cap?
Cochlear Limited’s market cap is AU$11.27B.
When is Cochlear Limited’s upcoming earnings report date?
Cochlear Limited’s upcoming earnings report date is Aug 13, 2026 which is in 129 days.
How were Cochlear Limited’s earnings last quarter?
Cochlear Limited released its earnings results on Feb 12, 2026. The company reported AU$2.98 earnings per share for the quarter, missing the consensus estimate of AU$3.151 by -AU$0.171.
Is Cochlear Limited overvalued?
According to Wall Street analysts Cochlear Limited’s price is currently Undervalued.
Does Cochlear Limited pay dividends?
Cochlear Limited pays a Semiannually dividend of AU$2.15 which represents an annual dividend yield of 1.64%. See more information on Cochlear Limited dividends here
What is Cochlear Limited’s EPS estimate?
Cochlear Limited’s EPS estimate is 3.25.
How many shares outstanding does Cochlear Limited have?
Cochlear Limited has 65,398,680 shares outstanding.
What happened to Cochlear Limited’s price movement after its last earnings report?
Cochlear Limited reported an EPS of AU$2.98 in its last earnings report, missing expectations of AU$3.151. Following the earnings report the stock price went down -18.898%.
Which hedge fund is a major shareholder of Cochlear Limited?
Currently, no hedge funds are holding shares in AU:COH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cochlear Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$247.69 (43.71% Upside)
AU$247.69 (43.71% Upside)
Insider Transactions
Bought Shares
Worth $116.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.38%
12-Months-Change
Fundamentals
Return on Equity
17.76%
Trailing 12-Months
Asset Growth
8.00%
Trailing 12-Months
Company Description
Cochlear Limited
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
COH Company Deck
COH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mixed picture: strategically positive with a largely successful Nexa launch, clear adoption in developed markets, services momentum and significant long‑term investments (cloud, R&D, capacity). However, near‑term financials were weaker than expected — H1 revenue down 2% cc, margin compression to 73%, A$103M cash decline and an A$30M potential FX hit for H2 — and the company experienced short‑term market share pressure during contracting and some softness in Acoustics. Management expects a stronger second half but guided to the lower end of prior FY guidance and emphasized that FX and timing delays constrained H1 results.View all AU:COH earnings summariesCOH Stock 12 Month Forecast
Average Price Target
AU$247.69
▲(43.71% Upside)
Technical Analysis
Nova Eye Medical
―
Compumedics Limited
―
Somnomed Limited
―
Control Bionics Ltd.
―
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―
Options Prices
Currently, No data available
---